Further, we investigated the survival compensatory pathways associated with RICTOR blockade, and we took a dual pathway inhibition approach to blunt rescue mechanism(s) to produce significant anti-tumor effects in vitro and in vivo. This evidence concerns the gene RICTOR and neoplasm.